Adrenal gland - INSM1 negative adrenocortical adenoma.
Adrenal gland - INSM1 negative adrenocortical carcinoma.
Adrenal gland - Pheochromocytoma showing moderate to strong INSM1 immunostaining in tumor cells.
Colon - Colorectal adenocarcinoma showing moderate to strong INSM1 immunostaining in a fraction of cells (30-50%).
Esophagus - INSM1 negative adenocarcinoma.
Esophagus - Squamous cell carcinoma showing weak INSM1 immunostaining in a small fraction of cells (<5%).
Ileum - Neuroendocrine tumor showing moderate INSM1 immunostaining in tumor cells.
Kidney - INSM1 negative clear cell renal cell carcinoma.
Kidney - INSM1 negative papillary renal cell carcinoma.
Larynx - INSM1 negative squamous cell carcinoma.
Liver - INSM1 negative cholangiocellular carcinoma.
Liver - INSM1 negative hepatocellular carcinoma.
Lung - INSM1 negative adenocarcinoma.
Lung - Neuroendocrine tumor with strong INSM1 positivity of tumor cells.
Lung - Small cell neuroendocrine carcinoma showing strong INSM1 immunostaining in most tumor cells.
Lymph node - Diffuse large B-cell lymphoma showing a weak to moderate INSM1 immunostaining in a fraction of cells (>50%).
Ovary - Endomeroid carcinoma showing a weak to moderate INSM1 immunostaining in tumor cells.
Pancreas - INSM1 negative acinar cell carcinoma.
Pancreas - Neuroendocrine tumor showing strong INSM1 immunostaining in tumor cells.
Pharynx - Squamous cell carcinoma showing moderate INSM1 immunostaining in a fraction of tumor cells (20-30%).
Pharynx - Squamous cell carcinoma showing moderate to strong INSM1 immunostaining in a fraction of tumor cells (30-50%).
Prostate - INSM1 negative adenocarcinoma (Gleason 3+3=6).
Prostate - Small cell neuroendocrine carcinoma exhibiting strong INSM1 immunostaining in tumor cells.
Salivary gland - INSM1 negative pleomorphic adenoma.
Skin - INSM1 negative malignant melanoma.
Skin - Merkel cell carcinoma with strong INSM1 positivity of tumor cells.
Stomach - INSM1 negative gastric adenocarcinoma.
Stomach - INSM1 negative gastrointestinal stromal tumor (GIST).
Testis - INSM1 negative seminoma.
Thymus - INSM1 negative thymoma containing some residual INSM1 positive thymic epithelial cells.
Thyroid - INSM1 negative papillary carcinoma.
Thyroid - Medullary carcinoma showing moderate to strong INSM1 immunostaining. Adjacent normal thyroid follicles are INSM1 negative.
Urinary bladder - INSM1 negative muscle-invasive urothelial carcinoma.
Urinary bladder - Small cell neuroendocrine carcinoma exhibiting strong INSM1 positivity in tumor cells.
Uterus - INSM1 negative endometroid carcinoma of the endometrium.